fragile X syndrome


Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.

fragile X syndrome

n.
An inherited disorder caused by a defective gene on the X chromosome and marked by intellectual disability, developmental disorders, enlarged testes, and facial abnormalities in males and by mild or no effects in heterozygous females.

fragile X syndrome


n.
a widespread form of mental retardation caused by a faulty gene on the X chromosome.
[1980–85]
References in periodicals archive ?
Turk explained how professionals and parents can identify symptoms of Fragile X syndrome, the most common identifiable inherited cause of intellectual disability worldwide.
She said: "Although Ryan had fragile X syndrome, he was a cheerful, outgoing, friendly boy who loved football and riding his bike.
An estimated 750,000 men carry the gene for fragile X syndrome.
Key words: unstable mutations, fragile X syndrome, myotonic dystrophy, molecular diagnsosis, Costa Rica.
Fragile X syndrome is a genetic condition caused by a single gene whose code is changed.
Fragile X syndrome (FXS) is the leading cause of inherited mental retardation, affecting approximately 50,000 persons in the United States (1).
Release date- 06082019 - Devon - Zynerba Pharmaceuticals, Inc.(NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the publication of data from the Phase 2 FAB-C (Treatment of Fragile X Syndrome Anxiety and Behavioral Challenges with CBD) clinical trial.
Zynerba remains on track to report top line results from the CONNECT-FX study in Fragile X Syndrome in the second half of 2019; The company has completed enrollment in its Phase 2 BELIEVE 1 clinical trial in children and adolescents with developmental and epileptic encephalopathies.
Tetra Discovery has initiated an investigational Phase 2 study of BPN14770 in adults with Fragile X Syndrome, an indication for which BPN14770 has received Orphan Drug Designation from the US Food and Drug Administration.
UK-based developer of pharmaceutical treatments for serious disorders of the central nervous system, Autifony Therapeutics, has been granted Orphan Drug Designation by the US Food and Drug Administration (FDA) for AUT00206 for the treatment of Fragile X Syndrome, the company reported on Monday.
From causing mild learning impairments to severe intellectual or cognitive impairments that are often referred to as symptoms of mental retardation, Fragile X syndrome (FXS) can cause a number of serious symptoms that can make it extremely difficult for a person to lead a normal life.
TEHRAN (FNA)- A class of FDA-approved cancer drugs may be able to prevent problems with brain cell development associated with disorders including Down syndrome and Fragile X syndrome, researchers found.
Full browser ?